Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents
- 8 October 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 122 (3), 324-330
- https://doi.org/10.1016/j.jconrel.2007.05.038
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Drug interactions in cancer therapyNature Reviews Cancer, 2006
- Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastasesMolecular Cancer Therapeutics, 2006
- Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent mannerBiochemical and Biophysical Research Communications, 2006
- Chemistry and biology of wortmanninOrganic & Biomolecular Chemistry, 2005
- Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug deliveryMolecular BioSystems, 2005
- Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor EfficacyBioconjugate Chemistry, 2004
- Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and StaurosporineMolecular Cell, 2000
- Block copolymer micelles as vehicles for drug deliveryJournal of Controlled Release, 1993